Literature DB >> 8285230

Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo.

H T Lee1, C I Thompson, A Hernandez, J L Lewy, F L Belloni.   

Abstract

To determine the effects of chronic in vivo stimulation of adenosine receptors, R-(-)-N6-(2-phenylisopropyl)adenosine (R-PIA), a selective A1 receptor agonist, was administered to rats as a continuous 7-day infusion (200 nmol/h). Inotropic and chronotropic responses of isolated atria to adenosine receptor agonists were markedly desensitized compared with the responses of atria from age-matched control animals. Carbachol's negative chronotropic effect was also attenuated, indicating a heterologous mode of desensitization. Antagonist radioligand binding assays indicated a 52% reduction in A1 adenosine receptor maximum binding, and competition binding assays revealed a significant loss of G protein-coupled high-affinity A1 receptors in atria from R-PIA-treated rats. Inhibitory G proteins (Gi) were significantly reduced, as quantified by immunoblot analysis, with no change in the amount of stimulatory G proteins. Ventricular membranes from R-PIA rats showed loss of Gi and uncoupling of A1 receptors, without a significant change in A1 receptor density. Thus chronic R-PIA infusion desensitized rat atrial muscle to the effects of adenosine receptor agonists via several regulatory adaptations, including downregulation of A1 adenosine receptors, uncoupling of A1 receptors from their associated G proteins, and loss of Gi proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285230     DOI: 10.1152/ajpheart.1993.265.6.H1916

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Partners for adenosine A1 receptors.

Authors:  Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Cold-induced reduction in Gi alpha proteins in brown adipose tissue. Effects on the cellular hypersensitization to noradrenaline caused by pertussis-toxin treatment.

Authors:  P Svoboda; L Unelius; A Dicker; B Cannon; G Milligan; J Nedergaard
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

3.  The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors:  David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells.

Authors:  D Vendite; J M Sanz; D M López-Alañon; J Vacas; A Andrés; M Ros
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  Partial adenosine A1 receptor agonists for cardiovascular therapies.

Authors:  Barbara E Albrecht-Küpper; Kirsten Leineweber; Peter G Nell
Journal:  Purinergic Signal       Date:  2011-11-12       Impact factor: 3.765

6.  Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate.

Authors:  Nissim Balas; Michael Arad; Babeth Rabinowitz; Asher Shainberg
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

7.  Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.

Authors:  M W Hashimi; J D Thornton; J M Downey; M V Cohen
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

8.  Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.

Authors:  Bruno Bragança; Nádia Oliveira-Monteiro; Fátima Ferreirinha; Pedro A Lima; Miguel Faria; Ana P Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2016-03-07       Impact factor: 5.810

9.  Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.

Authors:  Fabrice Rannou; Virginie Scotet; Pascale Marcorelles; Roxane Monnoyer; Cédric Le Maréchal
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.